3-151355245-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001393769.1(MED12L):​c.2517+6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.701 in 1,590,704 control chromosomes in the GnomAD database, including 395,713 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 45424 hom., cov: 31)
Exomes 𝑓: 0.69 ( 350289 hom. )

Consequence

MED12L
NM_001393769.1 splice_region, intron

Scores

2
Splicing: ADA: 0.002986
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.661
Variant links:
Genes affected
MED12L (HGNC:16050): (mediator complex subunit 12L) The protein encoded by this gene is part of the Mediator complex, which is involved in transcriptional coactivation of nearly all RNA polymerase II-dependent genes. The Mediator complex links gene-specific transcriptional activators with the basal transcription machinery. [provided by RefSeq, May 2010]
P2RY12 (HGNC:18124): (purinergic receptor P2Y12) The product of this gene belongs to the family of G-protein coupled receptors. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. This receptor is involved in platelet aggregation, and is a potential target for the treatment of thromboembolisms and other clotting disorders. Mutations in this gene are implicated in bleeding disorder, platelet type 8 (BDPLT8). Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 3-151355245-T-C is Benign according to our data. Variant chr3-151355245-T-C is described in ClinVar as [Benign]. Clinvar id is 1321163.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.912 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MED12LNM_001393769.1 linkuse as main transcriptc.2517+6T>C splice_region_variant, intron_variant ENST00000687756.1 NP_001380698.1
P2RY12NM_022788.5 linkuse as main transcriptc.-179-14485A>G intron_variant ENST00000302632.4 NP_073625.1 Q9H244A8K7T1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MED12LENST00000687756.1 linkuse as main transcriptc.2517+6T>C splice_region_variant, intron_variant NM_001393769.1 ENSP00000508695.1 A0A8I5KX78
P2RY12ENST00000302632.4 linkuse as main transcriptc.-179-14485A>G intron_variant 1 NM_022788.5 ENSP00000307259.4 Q9H244

Frequencies

GnomAD3 genomes
AF:
0.765
AC:
116267
AN:
151978
Hom.:
45371
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.919
Gnomad AMI
AF:
0.689
Gnomad AMR
AF:
0.770
Gnomad ASJ
AF:
0.697
Gnomad EAS
AF:
0.854
Gnomad SAS
AF:
0.858
Gnomad FIN
AF:
0.740
Gnomad MID
AF:
0.797
Gnomad NFE
AF:
0.665
Gnomad OTH
AF:
0.773
GnomAD3 exomes
AF:
0.748
AC:
185309
AN:
247806
Hom.:
70382
AF XY:
0.745
AC XY:
99865
AN XY:
133976
show subpopulations
Gnomad AFR exome
AF:
0.926
Gnomad AMR exome
AF:
0.817
Gnomad ASJ exome
AF:
0.709
Gnomad EAS exome
AF:
0.849
Gnomad SAS exome
AF:
0.850
Gnomad FIN exome
AF:
0.735
Gnomad NFE exome
AF:
0.665
Gnomad OTH exome
AF:
0.728
GnomAD4 exome
AF:
0.694
AC:
998275
AN:
1438608
Hom.:
350289
Cov.:
25
AF XY:
0.698
AC XY:
500692
AN XY:
716958
show subpopulations
Gnomad4 AFR exome
AF:
0.930
Gnomad4 AMR exome
AF:
0.813
Gnomad4 ASJ exome
AF:
0.706
Gnomad4 EAS exome
AF:
0.843
Gnomad4 SAS exome
AF:
0.846
Gnomad4 FIN exome
AF:
0.727
Gnomad4 NFE exome
AF:
0.661
Gnomad4 OTH exome
AF:
0.722
GnomAD4 genome
AF:
0.765
AC:
116382
AN:
152096
Hom.:
45424
Cov.:
31
AF XY:
0.772
AC XY:
57423
AN XY:
74342
show subpopulations
Gnomad4 AFR
AF:
0.919
Gnomad4 AMR
AF:
0.771
Gnomad4 ASJ
AF:
0.697
Gnomad4 EAS
AF:
0.855
Gnomad4 SAS
AF:
0.857
Gnomad4 FIN
AF:
0.740
Gnomad4 NFE
AF:
0.665
Gnomad4 OTH
AF:
0.771
Alfa
AF:
0.704
Hom.:
30013
Bravo
AF:
0.773
Asia WGS
AF:
0.824
AC:
2867
AN:
3478
EpiCase
AF:
0.675
EpiControl
AF:
0.676

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Nizon-Isidor syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 05, 2021- -
not provided Benign:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
15
DANN
Benign
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0030
dbscSNV1_RF
Benign
0.17
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7615865; hg19: chr3-151073033; COSMIC: COSV56381353; COSMIC: COSV56381353; API